Adage Capital Partners Gp, L.L.C. Cyma Bay Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$51 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.63 - $24.47 $18.9 Million - $36.6 Million	-1,497,000 Reduced 36.29%	2,628,000 $62.1 Million
Q3 2023 Nov 14, 2023	SELL	$10.86 - $17.62 $3 Million - $4.87 Million	-276,292 Reduced 6.28%	4,125,000 $61.5 Million
Q2 2023 Aug 14, 2023	BUY	$7.47 - $10.95 $14,133 - $20,717	1,892 Added 0.04%	4,401,292 $48.2 Million
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $22.9 Million - $37.4 Million	3,899,400 Added 779.88%	4,399,400 $38.4 Million
Q2 2022 Aug 15, 2022	SELL	$1.72 - $3.39 $1.72 Million - $3.39 Million	-1,000,000 Reduced 66.67%	500,000 $1.48 Million

Q1 2022 May 16, 2022	BUY	$2.77 - $3.64 $138,500 - $182,000	50,000 Added 3.45%	1,500,000 $4.67 Million
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $3.49 Million - $7.6 Million	-1,050,000 Reduced 42.0%	1,450,000 $10.5 Million
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $1.41 Million - $4.25 Million	1,000,000 Added 66.67%	2,500,000 $8.73 Million
Q2 2019 Aug 14, 2019	SELL	$6.05 - $13.66 $5.6 Million - $12.6 Million	-925,000 Reduced 38.14%	1,500,000 $10.7 Million
Q1 2019 May 15, 2019	BUY	$8.16 - $13.42 $2.16 Million - $3.55 Million	264,850 Added 12.26%	2,425,000 $32.2 Million
Q4 2018 Feb 14, 2019	BUY	$6.54 - $11.74 $1.21 Million - $2.17 Million	185,150 Added 9.37%	2,160,150 $17 Million
Q3 2018 Nov 14, 2018	SELL	$10.88 - $14.52 $5.44 Million - $7.26 Million	-500,000 Reduced 20.2%	1,975,000 $21.9 Million
Q2 2018 Aug 14, 2018	SELL	$10.66 - $14.38 $10.7 Million - $14.4 Million	-1,000,000 Reduced 28.78%	2,475,000 $33.2 Million
Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $1.76 Million - $2.96 Million	195,474 Added 5.96%	3,475,000 $45.1 Million
Q4 2017 Feb 14, 2018	BUY	$7.67 - $9.31 $1.57 Million - $1.9 Million	204,526 Added 6.65%	3,279,526 $30.2 Million
Q3 2017 Nov 14, 2017	BUY	$5.95 - $8.26 $18.3 Million - $25.4 Million	3,075,000	3,075,000 $24.8 Million

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.88M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account